Replies to post #78459 on Innovation Pharmaceuticals Inc (IPIX)

[TOB]

I don't see it that way.

Brings up the curious timing of the recent Aspire draw though. If he waited just a few more days the average price would have been 10-20% higher. There was also a mention of additional board members to vote on at a shareholder meeting. I find his recent email at odds with these items. -TheMonolith

Cellceutix and the Aspire Capital financing is a relationship, proof of which is that it has been renewed once already. The CEO will not be looking to micro-manage puts to Aspire to gain an advantage, rather he will draw funds as required.

IMO we should also keep in mind that a 10-20% higher share price doesn't change the amount that CTIX raises, just the number of shares placed at that price.

Really, not many chart traders are successful in determining timing and share price. In securities I trade, I almost always could have done 10-20% better, or less worse, assuming I was psychic.

But yes, clearly the CEO Leo has an inherent advantage in that he knows the timing of PRs and some events. If he where to time every placement to Aspire's disadvantage, I think this would damage the relationship with Aspire. On the contrary, I would think he wants his primary financier to be happy with the way things unfold, make money, and thus have a better chance at yet another financing round if desired.

Just my view and opinion.